Swiss Cardiovascular Center, Division of Clinical and Interventional Angiology, Inselspital, University of Bern, Bern, Switzerland.
Eur J Vasc Endovasc Surg. 2010 Apr;39(4):441-6. doi: 10.1016/j.ejvs.2009.12.029. Epub 2010 Feb 20.
Ectopic calcification and mediacalcinosis can be promoted by corticosteroid use. Aim of the present investigation is to describe macrovascular disease features in patients with long-term corticosteroid therapy and symptomatic lower limb peripheral arterial occlusive disease (PAD).
A consecutive series of 2783 patients undergoing clinical and angiographic work-up of PAD were screened for long-term (>5 years) corticosteroid use (group A). Comparison was performed to a randomly selected age-, sex- and risk factor-matched PAD control cohort from the same series without corticosteroid use (group B). Patients with diabetes mellitus or severe renal failure were excluded. Arterial calcification was evaluated by qualitative assessment on radiographic images. Severity of atherosclerotic lesions was analysed from angiographic images using a semi-quantitative score (Bollinger score).
In general, 12 patients (5 males, mean age 78.5 +/- 9.0 years) with 15 ischaemic limbs qualified to be enrolled in group A and were compared to 23 matching control patients (6 2 males, mean age 79.5 +/- 6 years) with 32 ischaemic limbs. Incompressibility of ankle arteries determined by measurement of the ankle-brachial index was seen in 12 limbs (80%) in group A compared to 3 limbs (9%) in group B (p = 0.0009). No significant difference was found comparing group A and B for segmental calcification, whereas comparison of the atherosclerotic burden using the angiographic severity score showed a significantly higher score at the infragenicular arterial level in group A (p = 0.001).
Findings suggest that the long-term corticosteroid therapy is associated with a distally accentuated, calcifying peripheral atherosclerosis inducing arterial incompressibility. This occlusion pattern is comparable to patients with renal failure or diabetes. Further research is required to support our observations.
皮质类固醇的使用可促进异位钙化和中层钙化。本研究旨在描述长期皮质类固醇治疗且伴有症状性下肢外周动脉阻塞性疾病(PAD)的患者的大血管疾病特征。
对 2783 例行 PAD 临床和血管造影检查的患者进行了连续筛查,以确定是否长期(>5 年)使用皮质类固醇(A 组)。将 A 组与同一系列中未使用皮质类固醇的随机选择的年龄、性别和危险因素匹配的 PAD 对照组(B 组)进行比较。排除糖尿病或严重肾衰竭患者。通过放射图像上的定性评估评估动脉钙化。使用半定量评分(Bollinger 评分)从血管造影图像分析动脉粥样硬化病变的严重程度。
一般而言,12 名患者(5 名男性,平均年龄 78.5±9.0 岁)的 15 条缺血肢体符合入组 A 组的条件,并与 23 名匹配的对照患者(6 名男性,平均年龄 79.5±6 岁)的 32 条缺血肢体进行了比较。在 A 组的 12 条肢体(80%)中可见踝动脉通过测量踝臂指数不能压缩,而在 B 组的 3 条肢体(9%)中未见(p=0.0009)。在比较 A 组和 B 组的节段性钙化时未发现明显差异,而在用血管造影严重程度评分比较动脉粥样硬化负担时,A 组在膝下动脉水平的评分明显更高(p=0.001)。
研究结果表明,长期皮质类固醇治疗与向远侧突出的钙化性外周动脉粥样硬化相关,导致动脉不可压缩。这种闭塞模式与肾衰竭或糖尿病患者相似。需要进一步的研究来支持我们的观察。